Cargando…
In vitro efficacy of Artemisia extracts against SARS-CoV-2
BACKGROUND: Traditional medicines based on herbal extracts have been proposed as affordable treatments for patients suffering from coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Teas and drinks containing extracts of Artemisia annua and Ar...
Autores principales: | Nie, Chuanxiong, Trimpert, Jakob, Moon, Sooyeon, Haag, Rainer, Gilmore, Kerry, Kaufer, Benedikt B., Seeberger, Peter H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424155/ https://www.ncbi.nlm.nih.gov/pubmed/34496903 http://dx.doi.org/10.1186/s12985-021-01651-8 |
Ejemplares similares
-
Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence
por: Tolksdorf, Beatrice, et al.
Publicado: (2021) -
Polysulfates Block SARS‐CoV‐2 Uptake through Electrostatic Interactions
por: Nie, Chuanxiong, et al.
Publicado: (2021) -
Graphene Sheets with Defined Dual Functionalities for the Strong SARS‐CoV‐2 Interactions
por: Donskyi, Ievgen S., et al.
Publicado: (2021) -
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2
por: Zhou, Yuyong, et al.
Publicado: (2021) -
Predicting glycosylation stereoselectivity using machine learning
por: Moon, Sooyeon, et al.
Publicado: (2020)